Media & Resources

Global Forum on TB Vaccines will take place October 8-10, 2024 — the first time the meeting will be hosted in the Americas, coming at a time of renewed attention to TB vaccine research and development.

The following commitments must be prioritized by Heads of State and Governments to accelerate the development and delivery of the new tools that are urgently needed to end TB.

New study of nearly 4,000 people of African ancestries led to identification of gene inhibiting HIV replication.

Taking place in Brisbane, Australia, this International AIDS Society (IAS) conference features the latest scientific research for progress against the HIV epidemic.

Germany commits to 9.2 million Euros for the next five years to support development of a safe, effective, affordable, and accessible tuberculosis vaccine.

Sequential immunization approach used furthers IAVI’s HIV vaccine development.

Wellcome and Gates Foundation announce plans to fund a Phase III clinical trial of the tuberculosis vaccine candidate M72 in adults.

This series of articles in PharmacoEconomics are designed to map evidence gaps and identify health economic research priorities for the HIV prevention field.